Clinical Trial Update: Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent [NA]

View source ↗

Summary

A prospective, randomized, multicenter trial evaluating the PROMUS Element stent conducted by Boston Scientific has completed, with results posted on 2024-11-20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Drugs mentioned

• PROMUS Element Stent (everolimus-eluting stent)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atherosclerosis, Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2024-11-20